ticlopidine has been researched along with Abnormalities, Autosome in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Severe aplastic anemia is a well-recognized complication of ticlopidine therapy that carries a high mortality." | 2.41 | Ticlopidine-induced aplastic anemia: development of chromosomal abnormalities and response to immunosuppressive therapy. ( Liebman, HA; Murata-Collins, JL; Pullarkat, VA; Rho, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pullarkat, VA | 1 |
| Rho, H | 1 |
| Murata-Collins, JL | 1 |
| Liebman, HA | 1 |
1 review available for ticlopidine and Abnormalities, Autosome
| Article | Year |
|---|---|
Ticlopidine-induced aplastic anemia: development of chromosomal abnormalities and response to immunosuppressive therapy.
Topics: Aged; Aged, 80 and over; Anemia, Aplastic; Bone Marrow; Chromosome Aberrations; Chromosome Disorders | 2000 |